Former Food and Drug Administration Commissioner Scott Gottleib has repeatedly said life in the United States won't truly be back to normal until a novel COVID-19 coronavirus vaccine is widely available. The most optimistic sources say that likely won't be for another 12 to 18 months, but in the meantime, Gottleib said, there could be some instances where limited doses could be accessible.
During a Sunday appearance on CBS' Face the Nation, Gottleib told host Margaret Brennan that if the coronavirus mounts a comeback in a specific U.S. city in the fall, there may be a protocol in which at least some of the potentially hundreds of thousands of doses of trial vaccines produced for testing could be provided to people. He said that wouldn't be the case for a national epidemic similar to the current situation, but the hope is that with a better understanding of how to combat the virus, epidemics will be more constrained should a second wave hit.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
-
Ozempic can curb alcohol cravings, study findsSpeed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
'Eras are an imprecise tool to make sense of the messy past'Instant Opinion Opinion, comment and editorials of the day
-
Magazine solutions - February 21, 2025Puzzles and Quizzes Issue - February 21, 2025
-
Ozempic can curb alcohol cravings, study finds
Speed read Weight loss drugs like Ozempic and Wegovy may also be helpful in limiting alcohol consumption
-
New form of H5N1 bird flu found in US dairy cowsSpeed Read This new form of bird flu is different from the version that spread through herds in the last year
-
Microplastics accumulating in human brains, study findsSpeed Read The amount of tiny plastic particles found in human brains increased dramatically from 2016 to 2024
-
FDA approves painkiller said to thwart addictionSpeed Read Suzetrigine, being sold as Journavx, is the first new pharmaceutical pain treatment approved by the FDA in 20 years
-
Study finds possible alternative abortion pillSpeed Read An emergency contraception (morning-after) pill called Ella could be an alternative to mifepristone for abortions
-
HMPV is spreading in China but there's no need to worryThe Explainer Respiratory illness is common in winter
-
Marty Makary: the medical contrarian who will lead the FDAIn the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
-
California declares bird flu emergencySpeed Read The emergency came hours after the nation's first person with severe bird flu infection was hospitalized
